D
Do Young Kim
Researcher at Yonsei University
Publications - 737
Citations - 18320
Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal ArticleDOI
Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia
Sung Hoon Choi,Ae Ri Chung,Wonseok Kang,Jun Yong Park,Jun Yong Park,Misol Lee,Shin Won Hwang,Do Young Kim,Do Young Kim,Seung Up Kim,Seung Up Kim,Sang Hoon Ahn,Seungtaek Kim,Kwang Hyub Han +13 more
TL;DR: Under hypoxic conditions, silencing of HIF-1β expression suppressed tumor cell growth and regulated the expression of tumor growth-related factors, such as vascular endothelial growth factor, epidermal growth factors, and hepatocyte growth factor.
Journal ArticleDOI
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Oidov Baatarkhuu,Hye Won Lee,Jacob George,Dashchirev Munkh-Orshikh,Baasankhuu Enkhtuvshin,Sosorbaram Ariunaa,Mohammed Eslam,Sang Hoon Ahn,Kwang Hyub Han,Do Young Kim +9 more
TL;DR: Investigating changes in the proportion of acute viral hepatitis types in Mongolia over the last decade found patients with more than one hepatitis virus infection were significantly older, more likely to be male and had a higher prevalence of all risk factors for disease acquisition.
Journal ArticleDOI
Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects.
Ha Young Woo,Hyungjin Rhee,Jeong Eun Yoo,Se Hoon Kim,Gi Hong Choi,Do Young Kim,Hyun Goo Woo,Hye Sun Lee,Young Nyun Park +8 more
TL;DR: In this paper, the pathological aspects of HCC metastases to various organs were characterized, including BCLC stage B-C, microvascular invasion (MVI), vessels encapsulating tumour clusters (VETC)-HCC, K19 and FAP expression, and CD163+ macrophage infiltration.
Journal ArticleDOI
Effect of urea cream on sorafenib-associated hand–foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study
Young-Sun Lee,Young Kul Jung,J.H. Kim,Sung B. Cho,Do Young Kim,Moon Young Kim,Hyung Joon Kim,Yeon Seok Seo,Ki Tae Yoon,Young Mi Hong,Jeong Hoon Lee,Hyun Woong Lee,Hyung Joon Yim,Byoung K. Jang,Eun Sun Jang,Jae Y. Jang,Sang Y. Hwang +16 more
TL;DR: Treatment with urea cream showed a lower incidence of severe sorafenib-induced HFSR at 2 weeks and reduced the tendency of HFSr development in HCC patients, and may be considered for prophylaxis or improvement of H FSR grade in H CC patients treated with sorafinib.
Journal ArticleDOI
Clinical features of re-emerging hepatitis A: an analysis of patients hospitalized during an urban epidemic in Korea.
Hee Kyoung Choi,Young Goo Song,Chang Oh Kim,So Youn Shin,Bum Sik Chin,Sang Hoon Han,Sung Joon Jin,Yun Tae Chae,Ji Hyeon Baek,Sun Bean Kim,Do Young Kim,Jun Yong Park,June Myung Kim,Jun Yong Choi +13 more
TL;DR: Widespread use of vaccine is warranted to reduce the burden of hepatitis A in Korea because the rate of severe or fulminant hepatitis have significantly increased during the latest epidemic.